Active-ingredient Dossier
Pemetrexed Disodium Hemipentahydrate
Active-ingredient Dossier for Pemetrexed Disodium Hemipentahydrate (antimetabolite chemotherapy agent). Australian brands, products, PBS listings, PBAC…
- Brand: PEMETREXED
- Brand: PEMETREXED EVER PHARMA
- Brand: PEMETREXED JUNO
- Brand: PEMETREXED-AFT
- Brand: EMEXED
- Therapeutic area: Oncology
What is
Pemetrexed Disodium Hemipentahydrate Pemetrexed Disodium Hemipentahydrate is an antimetabolite chemotherapy agent.
Australian brands containing
Pemetrexed Disodium Hemipentahydrate — PEMETREXED EVER PHARMA — PEMETREXED — EMEXED — PEMETREXED JUNO — PEMETREXED-AFT — APO-Pemetrexed — EUG-PEMETREXED — PEMETREXED SANDOZ
Therapeutic areas
Pemetrexed Disodium Hemipentahydrate is registered in Oncology, with eight brands containing the ingredient.
Sponsor landscape
The ingredient is marketed by seven sponsors: Eugia Pharma, Arrotex Pharmaceuticals, Emcure Pharmaceuticals, Interpharma, Juno Pharmaceuticals, and Sandoz.
PBS and regulatory activity
The latest PBAC outcome for pemetrexed-containing brands was recorded on 1 March 2023, with two brands having PBAC outcomes on record.